In addition, glioblastoma and RRMS patients shared higher fractions of KLRG1+ CD4+ TTE, whereas CD8+ effector and memory Tc were only elevated in RRMS patients compared to controls. This evidence concerns the gene KLRG1 and relapsing-remitting multiple sclerosis.